Patient Data. Exhibits Click to mark whether the assessment finding represents a therapeutic result of the minoxidil administered a, nontherapeutic side effect, or an unrelated finding. Each row must have one option selected.

Rationale: Dizziness while sitting up: Minoxidil is a potent arterial vasodilator that lowers systemic vascular resistance. The resulting orthostatic hypotension can reduce cerebral perfusion, producing dizziness when the patient moves from lying to sitting. This is a common nontherapeutic side effect that requires monitoring. Pain rated at 1 on a 0–10 scale: The improvement in pain is attributable to ibuprofen given earlier, not minoxidil. Analgesic effects are unrelated to the vasodilatory action of minoxidil. Blood glucose 218 mg/dL: Elevated glucose is unrelated to minoxidil. This finding reflects the client’s type 2 diabetes and possibly stress-induced hyperglycemia, but it is not a direct drug effect. Urine output 600 mL: Increased urine output is not linked to minoxidil. Diuresis would be expected from hydrochlorothiazide, a thiazide diuretic already prescribed to this client, rather than the vasodilatory action of minoxidil. Heart rate 99 beats/minute: Reflex tachycardia is a well-recognized consequence of minoxidil. As systemic vascular resistance falls, the baroreceptor reflex activates the sympathetic nervous system, increasing heart rate to maintain cardiac output. Mouth dryness: Dry mouth can result from systemic vasodilators like minoxidil, often secondary to sympathetic stimulation and altered salivary gland perfusion. While not life-threatening, it may reduce oral intake and patient comfort. Blood pressure 162/111 mm Hg: The patient’s blood pressure decreased from 203/166 mm Hg to 162/111 mm Hg after minoxidil administration, reflecting effective vasodilation and lowered afterload. This demonstrates the intended therapeutic outcome.